---
document_datetime: 2023-09-21 17:37:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/infanrix-hexa-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: infanrix-hexa-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.7814653
conversion_datetime: 2025-12-30 22:48:37.433298
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

For procedures finalised after 01 November 2002 please refer to module 8B.

| Scope                                                                                                                                                                                                                 | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Batch size of active substance                                                                                                                                                                                        | I/II/0001            | I/II                     | 25.01.01                            | 22.11.01                                 |
| Change in container shape                                                                                                                                                                                             | I/0002               | I                        | 22.01.01                            | 22.11.01                                 |
| Quality change (demonstration of TSE compliance)                                                                                                                                                                      | II/0003              | II                       | 15.11.01                            |                                          |
| Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                                           | I/0004               | I                        | 14.03.01                            | 22.11.01                                 |
| Changes to comply with supplements to pharmacopoeias                                                                                                                                                                  | I/0005               | I                        | 23.03.01                            | 22.11.01                                 |
| Change in test procedures of the medicinal product                                                                                                                                                                    | I/II/0006            | I/II                     | 26.04.01                            |                                          |
| Extension of shelf-life as foreseen at time of authorisation                                                                                                                                                          | I/0007               | I                        | 26.03.01                            | 16.07.01                                 |
| Extension of shelf-life as foreseen at time of authorisation                                                                                                                                                          | I/0008               | I                        | 14.06.01                            | 22.11.01                                 |
| Change(s) to the test method(s) and/or specifications for the active substance                                                                                                                                        | II/0009              | II                       | 23.08.01                            | 24.09.01                                 |
| Quality change                                                                                                                                                                                                        | II/0010              | II                       | 20.09.01                            |                                          |
| Change in the name of a manufacturer of the medicinal product                                                                                                                                                         | I/0011               | I                        | 05.11.01                            |                                          |
| Change of name ofMAH and manufacturer for batch release                                                                                                                                                               | I/0012               | I                        | 05.11.01                            |                                          |
| Change in the pack size for a medicinal product                                                                                                                                                                       | I/0013               | I                        | 07.11.01                            |                                          |
| Change in the pack size for a medicinal product                                                                                                                                                                       | I/0014               | I                        | 07.11.01                            |                                          |
| Change in the name of theMAH and manufacturer responsible for batch release                                                                                                                                           | I/0015               | I                        | 16.11.01                            |                                          |
| Quality: Change(s) to the test method(s) and/or specifications for the finished product                                                                                                                               | II/0016              | II                       | 30.05.02                            | 07.06.02                                 |
| Update of the Summary of Product Characteristics section 4.8 (Undesirable effects) and Package Leaflet (PL) to incorporate new safety information and minor changes on new details of some MAH local representatives. | II/0017              | II                       | 25.07.02                            | 24.10.02                                 |
| Quality: Change(s) to the test method(s) and/or specifications for the finished product Quality: Change(s) to the test method(s) and/or specifications for the active substance                                       | II/0018              | II                       | 17.10.02                            | 30.10.02                                 |
| Change in container shape                                                                                                                                                                                             | I/0019               | II                       | 20.09.02                            | 27.09.02                                 |